Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin for Pulmonary Perfusion in Alpha-1 Antitrypsin Deficiency
NCT03008915Phase 2Completed
- Sponsor
- Columbia University
- Start
- Jan 2017
- Primary completion
- Jul 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of aspirin in alpha-1 antitrypsin deficiency (AATD), sponsored by Columbia University. Started Jan 2017; status: completed.
02
Drugs
aspirin
03
Conditions
alpha-1 antitrypsin deficiency (AATD)
Beyond the preview
Go deeper on NCT03008915.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03008915.